Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2549252 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28200516 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL27789610 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL543806 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL28213061 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL20481865 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL7876335 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL9492117 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL20873675 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL3463764 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101811686-B | Magnesium-containing beta-tricalcium phosphate nanometer particle and preparation method thereof | UNIV CHONGQING | 2011-06-15 | — | — | CN | claimed |
| CN-101811686-A | Magnesium-containing beta-tricalcium phosphate nanometer particle and preparation method thereof | UNIV CHONGQING | 2010-08-25 | — | — | CN | claimed |
| EP-1948561-B1 | A PLURISUBSTITUTED HYDROXYAPATITE AND THE COMPOSITE THEREOF WITH A NATURAL AND/OR SYNTHETIC POLYMER, THEIR PREPARATION AND USES THEREOF | FIN CERAMICA FAENZA SPA (IT) | 2016-09-07 | — | — | EP | disclosed |
| CN-105582574-A | Magnesium-containing multiphase porous bioceramic | LI YAPING | 2016-05-18 | — | — | CN | disclosed |
| US-9327976-B2 | Plurisubstituted hydroxyapatite and the composite thereof with a natural and/or synthetic polymer, their preparation and uses thereof | C.N.R. CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2016-05-03 | — | — | US | disclosed |
| CN-101811686-B | Magnesium-containing beta-tricalcium phosphate nanometer particle and preparation method thereof | UNIV CHONGQING | 2011-06-15 | — | — | CN | disclosed |
| CN-101811686-A | Magnesium-containing beta-tricalcium phosphate nanometer particle and preparation method thereof | UNIV CHONGQING | 2010-08-25 | — | — | CN | disclosed |
| US-20080262121-A1 | silicate and carbonate anions, which partially substitute phosphate ions, on the other hand, Mg2+ and Sr2+ cations, which partially substitute calcium ions; natural or synthetic polymer selected from: gelatins, albumins, alginates, collagen, polylactic acid etc. biohybrid; biocompatibillity, biomimitic | FIN-CERAMICA FAENZA S.P.A. (IT) | 2008-10-23 | — | — | US | disclosed |
| US-20070172433-A1 | Biometic compounds containing hydroxyapatites substituted with magnesium and carbonate, and the processes used to obtain them | A. MENARINI INDUSTRIE FARMACEUTICHE REUNITE S.R.L. (IT) | 2007-07-26 | — | — | US | disclosed |
| EP-1740499-A1 | BIOMIMETIC COMPOUNDS CONTAINING HYDROXYAPATITES SUBSTITUTED WITH MAGNESIUM AND CARBONATE, AND THE PROCESSES USED TO OBTAIN THEM | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005082780-A1 | BIOMIMETIC COMPOUNDS CONTAINING HYDROXYAPATITES SUBSTITUTED WITH MAGNESIUM AND CARBONATE, AND THE PROCESSES USED TO OBTAIN THEM | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. | 2005-09-09 | — | — | WO | disclosed |